HelixPharma

Home

Research and Development

HelixPharma:

Raw material

with high technological value

Raw material

Safe, effective and controlled

Research activity

Conducted by highly qualified personnel

Consulting

We provide scientific support for

quality certifications e

new product registration

"Nature offers countless opportunities and great potential,

but only the Scientific Research can help us to make the best use".

This is what we believe in.

Slide title

Scrivi qui la tua didascalia

Button
Titolo diapositiva

Scrivi qui la tua didascalia

Pulsante
Slide title

Scrivi qui la tua didascalia

Button

Mission

HelixPharma was born as a Spinoff of the University of Ferrara, but being essentially composed of Researchers and teachers it soon became an Innovative StartUp. The innovation concerns both the production process and the products offered, in fact, in addition to having revolutionized the snail secretion production system, thanks to the expertise of its team, it is able to synthesize new compounds and test their effectiveness according to the needs of the snail. customer.

The GlicoPro® inside the new eyedrop "Lacricomplex"

15 Jul, 2021

After a long R&D process HelixPharma's Team is proud to announce that the own active substance called GlicoPro has been used for the eyedrop "Lacricomplex". The company expresses all its satisfaction in seeing one of its assets used in a Medical Device that for the unique characteristics scientifically validated by the University of Ferrara will represent an innovation in the treatment of the Dryeye.

Il GlicoPro nel nuovo Collirio Lacricomplex

Il GlicoPro® all'interno nel nuovo collirio "Lacricomplex"

11 May, 2021

Dopo un lungo processo di Ricerca e Sviluppo HelixPharma è lieta di annunciare che il proprio attivo GlicoPro è stato utilizzato per il collirio "Lacricomplex". La società esprime tutta la sua soddisfazione nel vedere uno dei suoi attivi utilizzati in un Dispositivo Medico che per le caratteristiche uniche validate scientificamente dall'Università di Ferrara rappresenterà un innovazione nell'ambito del trattamento del DryEye.